<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare health-related quality of life (HRQOL) of patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) with and without previous thrombovascular events (TE) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The Medical Outcomes Study Short-Form 36 (SF-36) was used to assess HRQOL in 5 patient groups: (1) primary APS (PAPS; n = 35); (2) APS associated to SLE (SAPS; n = 37); (3) SLE+TE without persistent positive <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> (SLE+TE-aPL; n = 75); (4) SLE-TE+aPL (n = 71); and (5) SLE-TE-aPL (n = 608) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The data on both mental component summary and physical component summary (PCS) scores showed an impaired quality of life in <z:hpo ids='HP_0000001'>all</z:hpo> patient groups </plain></SENT>
<SENT sid="3" pm="."><plain>Patients in the SLE+TE-aPL group had a lower PCS score compared to patients in the SLE-TE+aPL group </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: The combination of SLE and TE has a more negative influence on reported HRQOL, compared to having SLE or APS alone </plain></SENT>
</text></document>